07/16/2025
6:02 PM | BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/15/2025
8:00 AM | C4 Therapeutics (Issuer)
REYNO LEONARD (Reporting)
| Form 4/A | |
06/18/2025
3:50 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
7:09 PM | C4 Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
12:39 PM | C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
6:06 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
6:08 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
6:04 AM | C4 Therapeutics (Filer)
| Form ARS | |
04/29/2025
6:01 AM | C4 Therapeutics (Filer)
| Form DEF 14A | |
04/29/2025
6:02 AM | C4 Therapeutics (Filer)
| Form DEFA14A | |
04/16/2025
6:46 AM | C4 Therapeutics (Filer)
| Form PRE 14A | |
Get the Latest News and Ratings for CCCC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for C4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/14/2025
7:17 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:19 AM | C4 Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
6:07 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:15 AM | C4 Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/03/2025
12:59 PM | C4 Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G | |
01/14/2025
6:09 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:49 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:11 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:43 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
6:53 PM | C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:43 PM | C4 Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
11/14/2024
8:01 AM | C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
11:15 PM | C4 Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
11:15 PM | C4 Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
3:57 PM | C4 Therapeutics (Filer)
| Form SUPPL | |
11/13/2024
3:58 PM | C4 Therapeutics (Filer)
| Form SUPPL | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
10/31/2024
4:26 PM | C4 Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/31/2024
4:27 PM | C4 Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/31/2024
6:07 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:12 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
3:30 PM | C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
3:31 PM | C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
10/18/2024
3:45 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:11 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:37 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:10 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:11 PM | C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Microsoft's Next Big Bet? (Ad) Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-free energy. Bill Gates calls it “abundant” and is backing four separate startups in the space.
While most of these plays are off-limits to everyday investors, a little-known backdoor could give you access to one tiny company leading the charge—and it’s publicly traded. Get the name and ticker of this breakthrough energy stock before the window closes. |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:51 PM | C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
3:52 PM | C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:06 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free CCCC Stock Alerts